Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 869-871, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paavonen, J.
Right arrow Articles by Stenman, U. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paavonen, J.
Right arrow Articles by Stenman, U. H.

Clinical Chemistry, Vol 35, 869-871, Copyright © 1989 by American Association for Clinical Chemistry

Concentrations of tumor-associated trypsin inhibitor and C-reactive protein in serum in acute pelvic inflammatory disease

J Paavonen, M Lehtinen, M Lehto, S Laine, R Aine, L Rasanen and UH Stenman
Department of Obstetrics & Gynecology, University Central Hospital, Helsinki, Finland.

We measured tumor-associated trypsin inhibitor (TATI) and C-reactive protein (CRP) in serum of 29 patients with proven pelvic inflammatory disease (PID). TATI values were increased in seven (24%), paralleling increases in CRP. TATI was increased by about 3.5-fold in seven of eight patients with CRP concentrations greater than 90 mg/L, but in none of 21 patients with CRP concentrations less than 90 mg/L. TATI concentration and severity of PID as determined by laparoscopy or endometrial biopsy were not correlated. These results suggest that, in severe infections, regulation of TATI synthesis resembles that of acute- phase proteins.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
U.-H. Stenman
Tumor-associated Trypsin Inhibitor
Clin. Chem., August 1, 2002; 48(8): 1206 - 1209.
[Abstract] [Full Text] [PDF]

Home page
 Sex. Transm. Infect.Home page
J. Paavonen
Chlamydia trachomatis and cancer
Sex Transm Inf, June 1, 2001; 77(3): 154 - 156.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
M.-H. Schlageter, J. Larghero, B. Cassinat, M.-E. Toubert, C. Borschneck, and J.-D. Rain
Serum Carcinoembryonic Antigen, Cancer Antigen 125, Cancer Antigen 15-3, Squamous Cell Carcinoma, and Tumor-associated Trypsin Inhibitor Concentrations during Healthy Pregnancy
Clin. Chem., September 1, 1998; 44(9): 1995 - 1998.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.